The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations

Ugo Pagallo, Shane O’Sullivan*, Nathalie Nevejans, Andreas Holzinger*, Michael Friebe, Fleur Jeanquartier, Claire Jean-Quartier, Arkadiusz Miernik

*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in einer FachzeitschriftReview eines Fachbereichs (Review article)Begutachtung

Abstract

This contribution explores the underuse of artificial intelligence (AI) in the health sector, what this means for practice, and how much the underuse can cost. Attention is drawn to the relevance of an issue that the European Parliament has outlined as a" major threat" in 2020. At its heart is the risk that research and development on trusted AI systems for medicine and digital health will pile up in lab centers without generating further practical relevance. Our analysis highlights why researchers, practitioners and especially policymakers, should pay attention to this phenomenon.
Originalspracheenglisch
Seitenumfang14
FachzeitschriftHealth and Technology
Jahrgang14
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - Jan. 2024

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Angewandte Mikrobiologie und Biotechnologie
  • Biomedizintechnik

Fingerprint

Untersuchen Sie die Forschungsthemen von „The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren